Briacell reports Bria-MEL+ milestone for melanoma vaccine program
Briacell said it reported a genetic engineering milestone for Bria-MEL+, advancing the personalized whole-cell melanoma vaccine program toward clinical development.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.